From the Research
Origin of CJC-1295
- CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog, which suggests that it is manufactured in a research lab or pharmaceutical setting 1, 2, 3.
- The production of CJC-1295 is not limited to pharmaceutical companies, as it can also be manufactured illicitly 1.
- Studies have shown that CJC-1295 can be detected in unknown pharmaceutical preparations, indicating that it may be available from various sources, including research labs and pharmacies 1.
Availability and Distribution
- CJC-1295 is considered a prohibited substance under Section S2 of the WADA Prohibited List, which suggests that its distribution and use are regulated 1.
- The substance has potential performance-enhancing effects and is readily available, which may contribute to its use in certain communities, such as bodybuilding 1.
- Research studies have investigated the use of CJC-1295 in healthy adults and animals, which suggests that it may be available from research labs or pharmaceutical companies for research purposes 2, 3.
Detection and Analysis
- CJC-1295 can be detected in plasma samples using various methods, including immuno-polymerase chain reaction (I-PCR) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) 4, 5.
- The detection of CJC-1295 in equine plasma samples has been confirmed using LC-MS/MS after immuno-affinity capture and tryptic digestion 5.
- The development of methods for detecting CJC-1295 in plasma samples suggests that research labs and pharmaceutical companies may be involved in the analysis and regulation of this substance 4, 5.